https://www.selleckchem.com/pr....oducts/ssr128129e.ht
Lung cancer is one of the most common cancers and a leading cause of cancer-related death worldwide. Although many treatment options exist for lung cancer, some patients still suffer postoperative recurrence, and a consequent reduction of overall survival (OS). Our study aimed to investigate the correlation of FGF19 expression with the clinicopathological features and survival outcomes of non-small cell lung cancer (NSCLC) patients. Bioinformatics analysis was conducted using the data from The Cancer Genome Atlas (TCGA) database to d
Like
Comment
Share
